JGC

Flavin mononucleotide (semi-quinone intermediate)

Created:	2022-04-27
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where JGC is found as a standalone ligand2 entries where JGC is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	54
Chiral Atom Count	4
Bond Count	56
Aromatic Bond Count	6

2D diagram of JGC

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Flavin mononucleotide (semi-quinone intermediate)
Synonyms	[(2R,3S,4S)-5-[(4aR)-7,8-dimethyl-2,4-bis(oxidanylidene)-4a,5-dihydrobenzo[g]pteridin-10-yl]-2,3,4-tris(oxidanyl)pentyl] dihydrogen phosphate
Systematic Name (OpenEye OEToolkits)	[(2~{R},3~{S},4~{S})-5-[(4~{a}~{R})-7,8-dimethyl-2,4-bis(oxidanylidene)-4~{a},5-dihydrobenzo[g]pteridin-10-yl]-2,3,4-tris(oxidanyl)pentyl] dihydrogen phosphate
Formula	C₁₇ H₂₃ N₄ O₉ P
Molecular Weight	458.36
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	Cc1cc2N[CH]3C(=O)NC(=O)N=C3N(C[CH](O)[CH](O)[CH](O)CO[P](O)(O)=O)c2cc1C
SMILES	OpenEye OEToolkits	2.0.7	Cc1cc2c(cc1C)N(C3=NC(=O)NC(=O)C3N2)CC(C(C(COP(=O)(O)O)O)O)O
Canonical SMILES	CACTVS	3.385	Cc1cc2N[C@H]3C(=O)NC(=O)N=C3N(C[C@H](O)[C@H](O)[C@H](O)CO[P](O)(O)=O)c2cc1C
Canonical SMILES	OpenEye OEToolkits	2.0.7	Cc1cc2c(cc1C)N(C3=NC(=O)NC(=O)[C@@H]3N2)C[C@@H]([C@@H]([C@@H](COP(=O)(O)O)O)O)O
InChI	InChI	1.06	InChI=1S/C17H23N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(22)14(24)12(23)6-30-31(27,28)29/h3-4,11-14,18,22-24H,5-6H2,1-2H3,(H,20,25,26)(H2,27,28,29)/t11-,12+,13+,14-/m0/s1
InChIKey	InChI	1.06	JNFNEOXSUODPSY-DGAVXFQQSA-N

Related Resource References

Resource Name	Reference
PubChem	56603811

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.